Search

everythinglearnresearchcommunity

for

Search:↓

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

The document concludes that various topical medications are effective for skin conditions but often cause skin irritation as a side effect.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Psoriasis treatment may affect body hair growth, with a complex relationship between skin and hair growth mechanisms.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Finasteride helps female-pattern hair loss.

Higher RBP4 levels found in people with two types of hair loss.

Cyclosporin doesn't stop hair loss.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Platelet-rich plasma shows promise for skin and hair treatments but needs more research and standardization.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Platelet-rich plasma can potentially promote hair growth by stimulating cell growth and increasing certain proteins.

Melatonin in the skin helps protect against damage from stress and UV rays, and could be used to treat certain skin conditions.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Hair color production in mice is closely linked to the hair growth phase and may also influence hair growth itself.